About Synolo Therapeutics:
Synolo Therapeutics, an early-stage biotechnology company launched by RA Capital, is pioneering the development of precision-targeted immunotherapies. Powered by computational protein design and proprietary technologies which yield biological data sets at unprecedented scale and resolution, we are building a pipeline of first-in-class multi-specific biologics with novel functionalities. Synolo was founded by pioneers in the field of protein design and engineering, synthetic biology, DNA sequencing, immunology, and biologics drug discovery and development.
About RA Capital:
RA Capital Management funds and builds healthcare and life science companies using an evidence-based investment approach informed by TechAtlas, a think tank within RA Capital which analyzes scientific and clinical data from academic literature and industry sources to anticipate how breakthroughs might impact industry stakeholders, physicians, patients, and policymakers. TechAtlas' analyses are captured in a unique collection of competitive landscapes, or ‘maps’, that identify competitive therapeutics, diagnostics, research tools, and/or technological capabilities in a given area.
About the Role:
Synolo Therapeutics is seeking an innovative, self-motivated, and team-oriented Scientist or Senior Scientist in Biologics Discovery & Antibody Characterization with a passion for discovering and developing novel medicines and who thrives working in a fast-paced startup team. In this role, you will help conduct in-house biologics discovery and characterize multi-specific antibody drug candidates. You will support our cross-functional teams and be a key contributor to our drug discovery and development programs. As a member of a rapidly growing and very engaged team, you will help us in our mission to develop novel therapeutics to improve patients’ lives.
At Synolo Therapeutics, we are committed to fostering a diverse and inclusive work environment where all individuals are valued and treated with dignity. We believe that diversity drives innovation and strengthens our ability to make a meaningful impact through our work. We are committed to being an equal opportunity employer who ensures that all qualified applicants receive equal consideration for employment without regard to neurodiversity, race/ethnicity, color, national origin, religion, gender, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class.
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
At Synolo Therapeutics, we're on a mission to revolutionize healthcare through innovative biologics discovery, and we're looking for a passionate Scientist or Senior Scientist to join our vibrant team in Cambridge, MA. As part of our early-stage biotechnology company, you'll be at the forefront of developing precision-targeted immunotherapies using cutting-edge technologies and computational protein design. It's an exciting time to be part of our team as we create first-in-class multi-specific biologics that can have a significant impact on patients’ lives. In this role, you will dive into the nitty-gritty of antibody characterization and help us navigate the biologics discovery process. Your expertise will guide the engineering of multi-specific antibodies, optimizing them for both functionality and effectiveness. Collaboration is key, so you'll work closely with cross-functional teams, ensuring seamless communication of your findings. If you possess knowledge of antibody sequence classes, hands-on experience with advanced display techniques, and an entrepreneurial spirit, we want to hear from you! We're not just seeking qualifications; we value self-motivated, team-oriented individuals who thrive in a fast-paced startup environment. Let’s innovate together at Synolo Therapeutics and push the boundaries of what's possible in biologics and immunotherapy!
Subscribe to Rise newsletter